Markus Warmuth - President & CEO, Director at Monte Rosa Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
GLUE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Markus Warmuth since 4/22/2024

Holdings reported by Markus Warmuth for Monte Rosa Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 545K $5.12M $9.41 Jan 2, 2025 Direct
Stock Option (Right to Buy) 575K Jan 2, 2025 Direct Common Stock

Transactions reported by Markus Warmuth for Monte Rosa Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.